Papel de los biomarcadores en la miocardiopatía hipertrófica
La miocardiopatía hipertrófica (MCH) es una enfermedad primaria del miocardio causada por cambios genéticos. La MCH presenta hipertrofia cardíaca, desorganización de los miocitos e incremento de la matriz colágena intersticial que contribuyen al desarrollo de un amplio espectro de anomalías funciona...
Main Author: | Vílchez Aguilera, Juan Antonio |
---|---|
Other Authors: | Marín Ortuño, Francisco |
Format: | Doctoral Thesis |
Language: | Spanish |
Published: |
Universidad de Murcia
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/10803/117460 |
Similar Items
-
Effect of feline characteristics on plasma N‐terminal‐prohormone B‐type natriuretic peptide concentration and comparison of a point‐of‐care test and an ELISA test
by: Sofia Hanås, et al.
Published: (2020-05-01) -
Evaluación de biomarcadores cardiopulmonares durante diferentes etapas de Leishmaniasis visceral canina
by: Balikci Canberh, et al.
Published: (2018-01-01) -
Significance of NT-proBNP and High-sensitivity Troponin in Friedreich Ataxia
by: Lise Legrand, et al.
Published: (2020-05-01) -
Diagnostic value of cardiac troponin I and N-terminal pro-B-Type Natriuretic Peptide in cardiac syncope
by: Yan Liang, et al.
Published: (2021-01-01) -
N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
by: Jayachandran Thejus, et al.
Published: (2009-01-01)